Literature DB >> 19075189

New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.

José I Martín-Subero1, Markus Kreuz, Marina Bibikova, Stefan Bentink, Ole Ammerpohl, Eliza Wickham-Garcia, Maciej Rosolowski, Julia Richter, Lidia Lopez-Serra, Esteban Ballestar, Hilmar Berger, Xabier Agirre, Heinz-Wolfram Bernd, Vincenzo Calvanese, Sergio B Cogliatti, Hans G Drexler, Jian-Bing Fan, Mario F Fraga, Martin L Hansmann, Michael Hummel, Wolfram Klapper, Bernhard Korn, Ralf Küppers, Roderick A F Macleod, Peter Möller, German Ott, Christiane Pott, Felipe Prosper, Andreas Rosenwald, Carsten Schwaenen, Dirk Schübeler, Marc Seifert, Benjamin Stürzenhofecker, Michael Weber, Swen Wessendorf, Markus Loeffler, Lorenz Trümper, Harald Stein, Rainer Spang, Manel Esteller, David Barker, Dirk Hasenclever, Reiner Siebert.   

Abstract

Lymphomas are assumed to originate at different stages of lymphocyte development through chromosomal aberrations. Thus, different lymphomas resemble lymphocytes at distinct differentiation stages and show characteristic morphologic, genetic, and transcriptional features. Here, we have performed a microarray-based DNA methylation profiling of 83 mature aggressive B-cell non-Hodgkin lymphomas (maB-NHLs) characterized for their morphologic, genetic, and transcriptional features, including molecular Burkitt lymphomas and diffuse large B-cell lymphomas. Hierarchic clustering indicated that methylation patterns in maB-NHLs were not strictly associated with morphologic, genetic, or transcriptional features. By supervised analyses, we identified 56 genes de novo methylated in all lymphoma subtypes studied and 22 methylated in a lymphoma subtype-specific manner. Remarkably, the group of genes de novo methylated in all lymphoma subtypes was significantly enriched for polycomb targets in embryonic stem cells. De novo methylated genes in all maB-NHLs studied were expressed at low levels in lymphomas and normal hematopoietic tissues but not in nonhematopoietic tissues. These findings, especially the enrichment for polycomb targets in stem cells, indicate that maB-NHLs with different morphologic, genetic, and transcriptional background share a similar stem cell-like epigenetic pattern. This suggests that maB-NHLs originate from cells with stem cell features or that stemness was acquired during lymphomagenesis by epigenetic remodeling.

Entities:  

Mesh:

Year:  2008        PMID: 19075189     DOI: 10.1182/blood-2008-04-152900

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

1.  EZH2-mediated epigenetic silencing in germinal center B cells contributes to proliferation and lymphomagenesis.

Authors:  Irina Velichutina; Rita Shaknovich; Huimin Geng; Nathalie A Johnson; Randy D Gascoyne; Ari M Melnick; Olivier Elemento
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

2.  DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Rita Shaknovich; Huimin Geng; Nathalie A Johnson; Lucas Tsikitas; Leandro Cerchietti; John M Greally; Randy D Gascoyne; Olivier Elemento; Ari Melnick
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

3.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas.

Authors:  Christopher J Sneeringer; Margaret Porter Scott; Kevin W Kuntz; Sarah K Knutson; Roy M Pollock; Victoria M Richon; Robert A Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

4.  Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes.

Authors:  Nyasha Chambwe; Matthias Kormaksson; Huimin Geng; Subhajyoti De; Franziska Michor; Nathalie A Johnson; Ryan D Morin; David W Scott; Lucy A Godley; Randy D Gascoyne; Ari Melnick; Fabien Campagne; Rita Shaknovich
Journal:  Blood       Date:  2014-01-02       Impact factor: 22.113

Review 5.  Mechanisms of epigenetic deregulation in lymphoid neoplasms.

Authors:  Yanwen Jiang; Katerina Hatzi; Rita Shaknovich
Journal:  Blood       Date:  2013-05-23       Impact factor: 22.113

6.  Identification of common microRNA-mRNA regulatory biomodules in human epithelial cancers.

Authors:  Xinan Yang; Younghee Lee; Hong Fan; Xiao Sun; Yves A Lussier
Journal:  Chin Sci Bull       Date:  2010-11

7.  Array-based DNA methylation profiling of primary lymphomas of the central nervous system.

Authors:  Julia Richter; Ole Ammerpohl; José I Martín-Subero; Manuel Montesinos-Rongen; Marina Bibikova; Eliza Wickham-Garcia; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

8.  Epigenetic signatures associated with different levels of differentiation potential in human stem cells.

Authors:  Pablo Aranda; Xabier Agirre; Esteban Ballestar; Enrique J Andreu; José Román-Gómez; Inés Prieto; José Ignacio Martín-Subero; Juan Cruz Cigudosa; Reiner Siebert; Manel Esteller; Felipe Prosper
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

9.  A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.

Authors:  Jose I Martin-Subero; Ole Ammerpohl; Marina Bibikova; Eliza Wickham-Garcia; Xabier Agirre; Sara Alvarez; Monika Brüggemann; Stefanie Bug; Maria J Calasanz; Martina Deckert; Martin Dreyling; Ming Q Du; Jan Dürig; Martin J S Dyer; Jian-Bing Fan; Stefan Gesk; Martin-Leo Hansmann; Lana Harder; Sylvia Hartmann; Wolfram Klapper; Ralf Küppers; Manuel Montesinos-Rongen; Inga Nagel; Christiane Pott; Julia Richter; José Román-Gómez; Marc Seifert; Harald Stein; Javier Suela; Lorenz Trümper; Inga Vater; Felipe Prosper; Claudia Haferlach; Juan Cruz Cigudosa; Reiner Siebert
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

10.  Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.

Authors:  Ryan D Morin; Nathalie A Johnson; Tesa M Severson; Andrew J Mungall; Jianghong An; Rodrigo Goya; Jessica E Paul; Merrill Boyle; Bruce W Woolcock; Florian Kuchenbauer; Damian Yap; R Keith Humphries; Obi L Griffith; Sohrab Shah; Henry Zhu; Michelle Kimbara; Pavel Shashkin; Jean F Charlot; Marianna Tcherpakov; Richard Corbett; Angela Tam; Richard Varhol; Duane Smailus; Michelle Moksa; Yongjun Zhao; Allen Delaney; Hong Qian; Inanc Birol; Jacqueline Schein; Richard Moore; Robert Holt; Doug E Horsman; Joseph M Connors; Steven Jones; Samuel Aparicio; Martin Hirst; Randy D Gascoyne; Marco A Marra
Journal:  Nat Genet       Date:  2010-01-17       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.